Effect of All-trans Retinoic Acid With Chemotherapy Based on Paclitaxel and Cisplatin As First-line Treatment of Patients With Advanced Non-small Cell Lung Cancer and Expression of RAR-alfa and RAR-beta as Response Biomarker
Clinical trial NCT01041833 · UNKNOWN
Trial details
- NCT number
- NCT01041833
- Sponsor
- National Institute of Cancerología
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-01-01
- Primary completion
- 2011-09-01
- Enrollment
- 230
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.